Profile
Evi Fourka is currently an Associate at DECA Investments AIFM.
Prior to this role, Evi obtained a graduate degree from Bayes Business School in 2015 and an undergraduate degree from Athens University of Economics & Business in 2013.
Evi Fourka active positions
Companies | Position | Start |
---|---|---|
DECA Investments AIFM
DECA Investments AIFM Investment ManagersFinance DECA Investments AIFM is a private equity firm based in Greece that focuses on investing in Greek SMEs with strong growth potential. DECA Investments AIFM is based in Maroussi, Greece, and has subsidiaries in Luxembourg and Greece. The Greek company prioritizes sustainability and observes environmental protection and social management policies before and throughout their investments. DECA Investments is the exclusive investment manager of Diorama Investments SICAR, S.A. and Diorama Investments II RAIF, S.C.A. The portfolio includes companies in the brewery, generic pharmaceuticals, and diversified branded sectors. The private company was founded by Alexander Katsouridis, and the CEO is Nickolaos J. Koulis. | Analyst-Equity | 2016-07-31 |
Training of Evi Fourka
Bayes Business School | Graduate Degree |
Athens University of Economics & Business | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
DECA Investments AIFM
DECA Investments AIFM Investment ManagersFinance DECA Investments AIFM is a private equity firm based in Greece that focuses on investing in Greek SMEs with strong growth potential. DECA Investments AIFM is based in Maroussi, Greece, and has subsidiaries in Luxembourg and Greece. The Greek company prioritizes sustainability and observes environmental protection and social management policies before and throughout their investments. DECA Investments is the exclusive investment manager of Diorama Investments SICAR, S.A. and Diorama Investments II RAIF, S.C.A. The portfolio includes companies in the brewery, generic pharmaceuticals, and diversified branded sectors. The private company was founded by Alexander Katsouridis, and the CEO is Nickolaos J. Koulis. | Finance |
- Stock Market
- Insiders
- Evi Fourka